Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld et al. · The Lancet · 1999 · 2.3K citations

Inflammation, Rheumatology, Rheumatoid Disorder +14

Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis

Daniel J. Lovell, Edward H. Giannini, Andreas Reiff et al. · New England Journal of Medicine · 2000 · 1.2K citations · Full text

Respiratory and Limb Muscle Weakness Induced by Tumor Necrosis Factor- <b>α</b>

Michael B. Reid, Jan Lännergren, Håkan Westerblad · American Journal of Respiratory and Critical Care Medicine · 2002 · 318 citations

Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis

Adam M. Huber, Bianca Lang, Claire LeBlanc et al. · Arthritis & Rheumatism · 2000 · 270 citations

TNFα-308A allele in juvenile dermatomyositis: Association with increased production of tumor necrosis factor α, disease duration, and pathologic calcifications

Lauren M. Pachman, Margaret R. Liotta-Davis, David K. Hong et al. · Arthritis & Rheumatism · 2000 · 247 citations